Literature DB >> 3594482

Canine lymphoma-associated antigens defined by murine monoclonal antibodies.

Z Steplewski, K A Jeglum, C Rosales, N Weintraub.   

Abstract

Lymphoma in dogs resembles human non-Hodgkin's lymphoma in pathological presentation, immunophenotype, and response to therapy, thus representing a good model for comparative studies with human disease. Monoclonal antibodies (MAbs) were derived from mice immunized with a dog lymphoma cell line. Three MAbs were selected for further application in immunophenotyping and immunotherapy. The binding specificities, antigen characterization, and isotypes for these MAbs are described.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3594482     DOI： 10.1007/bf00205629

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN： 0340-7004            Impact factor:   6.968


  35 in total

1.  A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines.

Authors:  J F Kearney; A Radbruch; B Liesegang; K Rajewsky
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

2.  SEPARATION OF WHITE BLOOD CELLS.

Authors:  A BOYUM
Journal:  Nature       Date:  1964-11-21       Impact factor: 49.962

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Separation of functional subsets of human T cells by a monoclonal antibody.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

5.  Development and characterization of a hybridoma-derived antibody (Aby 1A1) with specificity to canine thymocytes and peripheral T lymphocytes.

Authors:  D R Krawiec; C C Muscoplat
Journal:  Am J Vet Res       Date:  1984-03       Impact factor: 1.156

6.  Induction of mouse IgG2a- and IgG3-dependent cellular cytotoxicity in human monocytic cells (U937) by immune interferon.

Authors:  Y Akiyama; M D Lubeck; Z Steplewski; H Koprowski
Journal:  Cancer Res       Date:  1984-11       Impact factor: 12.701

7.  Antigen attachment in ELISA.

Authors:  O P Lehtonen; M K Viljanen
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

8.  Principles of blood separation and component extraction in a disposable continuous-flow single-stage channel.

Authors:  J P Hester; R M Kellogg; A P Mulzet; V R Kruger; K B McCredie; E J Freireich
Journal:  Blood       Date:  1979-07       Impact factor: 22.113

9.  IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells.

Authors:  D Herlyn; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

10.  Phenotyping of canine lymphoma with monoclonal antibodies directed at cell surface antigens: classification, morphology, clinical presentation and response to chemotherapy.

Authors:  F R Appelbaum; G E Sale; R Storb; K Charrier; H J Deeg; T Graham; J C Wulff
Journal:  Hematol Oncol       Date:  1984 Apr-Jun       Impact factor: 5.271
View more
  11 in total

1.  Feasibility and Safety of RNA-transfected CD20-specific Chimeric Antigen Receptor T Cells in Dogs with Spontaneous B Cell Lymphoma.

Authors:  M Kazim Panjwani; Jenessa B Smith; Keith Schutsky; Josephine Gnanandarajah; Colleen M O'Connor; Daniel J Powell; Nicola J Mason
Journal:  Mol Ther       Date:  2016-07-12       Impact factor: 11.454

2.  Resistance of canine lymphoma cells to adenoviral infection due to reduced cell surface RGD binding integrins.

Authors:  Ann Marie O'Neill; Annette N Smith; Elizabeth A Spangler; Elizabeth M Whitley; Stephanie E Schleis; Richard C Bird; David T Curiel; Erin E Thacker; Bruce F Smith
Journal:  Cancer Biol Ther       Date:  2011-04-01       Impact factor: 4.742

Review 3.  Man's best friend: what can pet dogs teach us about non-Hodgkin's lymphoma?

Authors:  Kristy L Richards; Steven E Suter
Journal:  Immunol Rev       Date:  2015-01       Impact factor: 12.988

4.  Non-immunosuppressive FTY720-derivative OSU-2S mediates reactive oxygen species-mediated cytotoxicity in canine B-cell lymphoma.

Authors:  R Mani; R Yan; X Mo; C-S Chen; M A Phelps; R Klisovic; J C Byrd; W C Kisseberth; C A London; N Muthusamy
Journal:  Vet Comp Oncol       Date:  2016-05-02       Impact factor: 2.613

5.  FLT3 mutations in canine acute lymphocytic leukemia.

Authors:  Steven E Suter; George W Small; Eric L Seiser; Rachael Thomas; Matthew Breen; Kristy L Richards
Journal:  BMC Cancer       Date:  2011-01-27       Impact factor: 4.430

6.  Metabolic Abnormalities Detected in Phase II Evaluation of Doxycycline in Dogs with Multicentric B-Cell Lymphoma.

Authors:  Kelly R Hume; Skylar R Sylvester; Lucia Borlle; Cheryl E Balkman; Angela L McCleary-Wheeler; Mary Pulvino; Carla Casulo; Jiyong Zhao
Journal:  Front Vet Sci       Date:  2018-02-26

7.  The histone deacetylase inhibitor panobinostat is a potent antitumor agent in canine diffuse large B-cell lymphoma.

Authors:  Joana N R Dias; Sandra I Aguiar; Diane M Pereira; Ana S André; Lurdes Gano; João D G Correia; Belmira Carrapiço; Barbara Rütgen; Rui Malhó; Conceição Peleteiro; João Goncalves; Cecília M P Rodrigues; Solange Gil; Luís Tavares; Frederico Aires-da-Silva
Journal:  Oncotarget       Date:  2018-06-19

8.  Arginase treatment prevents the recovery of canine lymphoma and osteosarcoma cells resistant to the toxic effects of prolonged arginine deprivation.

Authors:  James W Wells; Christopher H Evans; Milcah C Scott; Barbara C Rütgen; Timothy D O'Brien; Jaime F Modiano; Goran Cvetkovic; Slobodan Tepic
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

9.  In vitro antineoplastic effects of auranofin in canine lymphoma cells.

Authors:  Hong Zhang; Barbara J Rose; Alex A Pyuen; Douglas H Thamm
Journal:  BMC Cancer       Date:  2018-05-03       Impact factor: 4.430

10.  Alkylation and Carbamylation Effects of Lomustine and Its Major Metabolites and MGMT Expression in Canine Cells.

Authors:  Thushara Chakkath; Sidonie Lavergne; Timothy M Fan; David Bunick; Levent Dirikolu
Journal:  Vet Sci       Date:  2015-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.